Here's How Many Shares of SCHD You'd Need for $1,000 in Yearly Dividends

Charles Schwab U.S. Dividend Equity ETF (SCHD) is a 102-stock dividend-focused ETF with a current yield of 3.8% and a most recent quarterly payout of $0.2782; its last four distributions totaled $1.0476, meaning an investor would need roughly 955 shares at the Dec. 11 price of $27.68 (about $26,435) to receive $1,000 annually. SCHD screens for quality by requiring constituents to have 10 consecutive years of dividend increases and healthy balance sheets to avoid yield traps, and its top holdings include Cisco (4.75%), Merck (4.65%) and Amgen (4.45%). The combination of a above-S&P yield and quality-focused index construction positions SCHD as a core income ETF for dividend-oriented portfolios, though it was not included in a separate analyst team’s list of top stock picks.

Analysis

The Charles Schwab U.S. Dividend Equity ETF (SCHD) is a 102-stock, dividend-focused ETF with a most recent quarterly payout of $0.2782 and four trailing distributions of $0.2782, $0.2604, $0.2602 and $0.2488 totaling $1.0476 for the past 12 months. As of market close on Dec. 11 the ETF traded at $27.68, implying a current yield of 3.8% versus a three-year average yield of 3.6%, and an investor would need roughly 955 shares (~$26,435) at that price to receive $1,000 of annual cash flow if payouts remain constant.

SCHD’s index construction requires constituents to have 10 consecutive years of dividend increases and “healthy balance sheets,” which biases the portfolio toward high-quality, established payers and is intended to reduce yield-trap risk. The top three holdings are Cisco (4.75%), Merck (4.65%) and Amgen (4.45%), indicating modest concentration among large-cap defensives and replaying a quality-income sector footprint.

Market signals are mildly positive and the ETF is positioned as a core income sleeve rather than a high-growth selection—note it was not included in a separate Stock Advisor top-10 stock pick list. Key risks are dividend and price volatility (yield moves with price), potential concentration in top holdings and exclusion of higher-growth names, so investors should monitor payout sustainability at the holding level and overall price-driven yield expansion.

Key Decisions for Investors

• Consider SCHD as a core, quality-focused income allocation for portfolios seeking a mid-single-digit yield, but size positions recognizing you need sizable capital to generate meaningful cashflow at current payouts
• Monitor yield versus the three-year average and investigate any yield spike driven by price declines by checking dividend sustainability and balance-sheet health of top holdings (Cisco, Merck, Amgen)
• Prefer SCHD for income stability rather than aggressive total-return exposure given its 10-year dividend-growth screen and exclusion of many high-growth names; complement with growth-oriented holdings if total-return is a priority
• Manage concentration risk by tracking weightings of the top holdings and set alerts for dividend cuts or material balance-sheet deterioration among the largest constituents